Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Track Record In Risk Communication Raised As Key Sentinel Concern

Executive Summary

FDA's ongoing challenges with effectively communicating the risks indicated by postmarket safety signals need to be resolved before the agency activates its Sentinel surveillance program, a number of participants said during a Dec. 16 FDA workshop

You may also be interested in...



FDA Surveying Doctors To Assess Impact Of Early Risk Communications

Findings from an FDA survey of physicians about their use and perceptions of emerging drug risk information could add a new tenor to the debate over the value of communicating early risk signals

FDA Surveying Doctors To Assess Impact Of Early Risk Communications

Findings from an FDA survey of physicians about their use and perceptions of emerging drug risk information could add a new tenor to the debate over the value of communicating early risk signals

FDA Post-Market Safety Efforts Won’t Be Impacted By Sentinel In Near Term

FDA's Sentinel post-market safety monitoring project will augment, not replace, the agency's current repertoire of post-market activities and requirements for drugs, Center for Drug Evaluation and Research Director Janet Woodcock emphasized

Related Content

Topics

UsernamePublicRestriction

Register

PS050503

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel